alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Summary of Compensation for named Executive Officers 2012



 Exhibit 10.34 
 Summary of Compensation for Named Executive Officers for Fiscal 2012 
 The
following represents the 2012 salary and target bonus applicable to the named executive officers as follows: 
  

									
	 Named Executive
	  	2012
Base Salary 
($)	 	 	2012
Target Bonus ($)	 
	 Arthur G. Dauber
	  	 	120,000	  	 	 	20,000	  
	 Charles M. Dauber
	  	 	250,000	* 	 	 	150,000	  
	 Neal T. Hare
	  	 	187,000	  	 	 	90,000	  
	 James J. Steffek
	  	 	187,000	  	 	 	90,000	  
	 Frances P. Hawes
	  	 	176,820	* 	 	 	82,500	  
	 Timothy C. Adams
	  	 	155,000	  	 	 	41,000	  

  

	*	Eligible for additional annual retention bonus subject to continued employment, $25,000 for Charles M. Dauber and $20,000 for Frances P. Hawes.


 Actual bonus amounts payable to each executive will be based on the achievement of 2012 Company and individual
performance goals established for each executive. Targeted performance must be achieved at the 70% to 75% level for that component of the bonus to be earned and must be achieved at the 100% level for the full bonus to be earned. Some of the each
executive’s individual goals may require a subjective evaluation and judgment with respect to achievement of these goals. Company performance targets range from 50% to 75% of total bonus with individual goals encompassing the remainder.

 In connection with the 2012 salary and target bonus established for the named executive officers, the following named
executive officers were awarded restricted stock units under the 2007 Employee Stock Incentive Plan. Each restricted stock unit issued one share of common stock upon vesting: 

 

					
	 Named Executive
	  	Restricted Stock Units	 
	 Charles M. Dauber
	  	 	80,000	  
	 Frances P. Hawes
	  	 	20,000	  
	 Tim C. Adams
	  	 	12,000	  

 Vesting of a portion of such awards is subject to achievement of the 2012 Company and individual
performance goals established for each executive, 9,600 for Mr. Adams, 64,000 for Mr. Dauber, and 16,000 for Ms. Hawes. The balance of such awards are subject to only a continuing employment requirement. All vested restricted stock
units convert into common stock on a one-to-one basis in four equal installments form the original grant date, subject to a continuing employment requirement.
World TB Day

£423 March 24
[Federal Register Volume 63, Number 146 (Thursday, July 30, 1998)]
[Notices]
[Page 40725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20296]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel Pharmacology Program Project 
Application.
    Date: August 7, 1998.
    Time: 8:30 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Brookline, 1200 Beacon Street, Brookline, MA 
02146.
    Contact Person: Irene B. Glowinski, PhD, Scientific Review 
Administrator, Office of Scientific Review, NIGMS, Natcher Building, 
Room 1AS-13, Bethesda, MD 20815, (301) 594-2772.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: July 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-20296 Filed 7-29-98; 8:45 am]
BILLING CODE 4140-01-M
STANDARD REVIEW ENGINEERING REPORT CBI: No

PMN: 09-0056 & 57 

Standard Review Draft 12/24/2008 

ENGINEER: Arnold \ CPW 

PV (kg/yr):

SUBMITTER:

USE: 

OTHER USES:

MSDS: Yes Label: No 

Gen Eqpt: safety glasses or goggles/ chemical resistant gloves 

and protective clothing/ adequate ventilation 

Respirator: follow OSHA respirator regulations 

Health Effects: Irritating to eyes and respiratory system/ 

slight skin irritation may occur/ may irritate gastrointestinal 

tract/ mucus membrane irritant 

TLV/PEL: 

none established 

CRSS : 

Chemical Name: [5,6]Fullerene-C84-D2 

S-H20: 0.000001 g/L @ 

VP: 1.0E-6 torr @ 

MW: 841.00 %<500 %<1000 

Physical State and Misc CRSS Info: 

Neat: Mfg: Proc/Form: End Use:
Consumer Use: 

SAT (concerns) (11/21/2008): 

Related Cases and Related Cases and Misc SAT Info: 

. 

Migration to groundwater: U 

PBT rating: P1B1T1 LVE PBT Rating is PU BU T1 

Health: 2 Dermal, Inhalation 

Eco: 1 No releases to Water 

OCCUPATIONAL EXPOSURE RATING: 1-2B 

NOTES & KEY ASSUMPTIONS: 

Generated by the 06/07/2005 version of ChemSTEER.

POLLUTION PREVENTION CONSIDERATIONS: 

P2 Claim: 

EXPOSURE-BASED REVIEW: No 
STANDARD REVIEW ENGINEERING REPORT CBI: No

PMN: 09-0056 & 57 

Number of Sites/ Location:

Days/yr: 

Basis: 

Process Description:

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY 

IRER Note: The daily releases listed for any source below may 

coincide with daily releases from the other sources to the same 

medium. Note: Water not required per SAT. 

OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY 

Tot. # of workers exposed via assessed routes:

Basis: 
Inhalation: 

Dermal: 
STANDARD REVIEW ENGINEERING REPORT CBI: No

PMN: 09-0056 & 57 

Number of Sites/ Location:

Days/yr: 

Basis: 

Process Description: 

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY 

IRER Note: The daily releases listed for any source below may 

coincide with daily releases from the other sources to the same 

medium. Note: Water not required per SAT. 
OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY 

Tot. # of workers exposed via assessed routes:

Basis: 

Inhalation:

Dermal: 
STANDARD REVIEW ENGINEERING REPORT CBI: No

PMN: 09-0056 57 

Number of Sites/ Location:

unknown site(s) 

Days/yr:

Basis: 

Process Description:

ENVIRONMENTAL RELEASES ESTIMATE SUMMARY 

IRER Note: The daily releases listed for any source below may 

coincide with daily releases from the other sources to the same 

medium. Note: Water not required per SAT. 
OCCUPATIONAL EXPOSURES ESTIMATE SUMMARY 

Tot. # of workers exposed via assessed routes:

Basis: 

Inhalation: 

Dermal:
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk July 26, 2010

0719 

# Order

July 26, 2010

140890

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 140890 COA: 295874 Berrien CC: 2008-405734-FC JOSHUA ALAN COLLINS, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal th e February 12, 2010 order of the Court of Appeals is consider ed, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.
# 2014 Codebook

# IISAR 2014
[Federal Register Volume 63, Number 144 (Tuesday, July 28, 1998)]
[Notices]
[Page 40331]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20031]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration


Executive Committee of the Aviation Rulemaking Advisory 
Committee; Meeting

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of a 
meeting of the Executive Committee of the Federal Aviation 
Administration Aviation Rulemaking Advisory Committee.

DATES: The meeting will be held on August 12, 1998, at 10 a.m.

ADDRESSES: The meeting will be held at the Aerospace Industries 
Association of America, 1250 Eye Street, NW., Goddard Room, Washington, 
DC.

FOR FURTHER INFORMATION CONTACT:
Miss Jean Casciano, Federal Aviation Administration, 800 Independence 
Avenue, SW., Washington, DC 20591, telephone (202) 267-9683; fax (202) 
267-5075; e-mail Jean.C<a href="/cdn-cgi/l/email-protection#48293b2b21292627082e2929662c273c662f273e"><span class="__cf_email__" data-cfemail="d4b5a7b7bdb5babb94b2b5b5fab0bba0fab3bba2">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463; 5 U.S.C. App. II), notice is 
hereby given of a meeting of the Executive Committee to be held on 
August 12, 1998, at the Aerospace Industries Association of America, 
1250 Eye Street, NW., Goddard Room, Washington, DC, 10 a.m. The agenda 
will include:
    <bullet>  A discussion of proposed new tasks for General Aviation 
and Business Airplane Issues and Transport Airplane and Engine Issues
    <bullet> Administrative issues
    Attendance is open to the interested public but will be limited to 
the space available. The public must make arrangements by August 3, 
1998, to present oral statements at the meeting. The public may present 
written statements to the executive committee at any time by providing 
25 copies to the Executive Director, or by bringing the copies to him 
at the meeting.
    Sign and oral interpretation can be made available at the meeting, 
as well as an assistive listening device, if requested 10 calendar days 
before the meeting. Arrangements may be made by contacting the person 
listed under the heading FOR FURTHER INFORMATION CONTACT.

    Issued in Washington, DC, July 21, 1998.
Joseph A. Hawkins,
Executive Director, Aviation Rulemaking Advisory Committee.
[FR Doc. 98-20031 Filed 7-27-98; 8:45 am]
BILLING CODE 4910-13-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Date of Posting...................

Date for Receipt of Quotes....

Cutoff Time for Receipt.........

Item #

(K0000) Location Origin

# of 

Units Bulk Wt (lbs) WO3 (%)

NOTE: Minimum bid is one entire line item.

* All quotes must be submitted through the DLA-Strategic Materials Sales Portal

and quoters must be pre-approved in the site to participate

DLA - Strategic Materials Sales Portal

Tungsten Ores and Concentrates Offering

FISCAL YEAR 2023

Basic Ordering Agreement... DLA-Stockpile Materials-001-(BOA) - Tungsten Ores & Concentrates

February 27, 2023

February 28, 2023

12:00pm

WO3 

(lbsWO3) W (lbsW ) WO3 (STU) Lot # Type

Total Total Total Total Total

731 Scotia, NY P-3129-C Synthetic Scheelite Unknown 217 79148 73.19 57928.421 45937.238 2896.436

851 Scotia, NY P-3167-A Synthetic Scheelite Unknown 257 83304 72.57 60453.713 47939.794 3022.642

1426 Scotia, NY 2403-19 Wolframite Thailand 41 55449 72.09 39973.184 31698.735 1998.666

1433 Scotia, NY P-2626 Wolframite Unknown 185 110360 69.14 76302.904 60508.203 3815.121

1667 Scotia, NY JCS-LISBON Wolframite Portugal 57 21528 68.27 14697.166 11654.852 734.869

757 349,789 249,355 197,739 12,468
Tin Offering

Item/Lot

1760

Brand

Long Horn 

Tin Content %

99.8

Lead Content %

0.05

Net Wt. (Lbs)

132,277

Metric Tons

60

Min. Bid (Lbs)

11,023.10

Location

Hammond, IN

* All quotes must be submitted through the DLA-Strategic Materials Sales Portal

and quoters must be pre-approved in the site to participate

DLA - Strategic Materials Sales Portal

Unit of Measure................... Lbs Offering Posting Time............

June 13, 2022

June 14, 2022

9:30am

12:00pm

FISCAL YEAR 2022

Basic Ordering Agreement... Tin Date of Posting...................

Grade................................. A Date for Receipt of Quotes....

Cutoff Time for Receipt.........

Quality

A
National Center for Emerging and Zoonotic Infectious Diseases

WORK GROUP PLANS AND TIMELINES

Nicole Lindsey, MS

CDC Deputy Lead, Chikungunya Vaccines Work Group

Arboviral Diseases Branch

Centers for Disease Control and Prevention

ACIP meeting

February 23, 2023
Work Group timeline (tentative)

Dec Jan Feb Mar Apr May Jun Jul Aug Sept

2024

(Today) Global 

epidemiology, 

US traveler, and 

chronic 

arthralgia data

Present EtR to 

ACIP

Present to ACIP 

other data 

relevant to 

recommendations

ACIP vote on vaccine 

recommendations for 

adult travelers and 

laboratory workers

Oct Nov Dec Jan Feb Mar Apr

BLA 

submission 

completed

2023

FDA determination 

on priority review Possible licensure
Summary of Work Group plans and activities

 Comprehensive review of immunogenicity and safety data (GRADE)

 Future presentations to ACIP on topics relevant to consideration of vaccine 

use in U.S. territories and states with risk of transmission

 Over longer term, additional vaccine data in younger age groups and/or 

additional chikungunya vaccines
Thank you
This document is in Ukrainian, a language that cannot be made 508-compliant for US-based readers or web 

users. See https://www.cdc.gov/vaccines/parents/diseases/child/vpd-infographics/measles.html for an 

English-language 508-compliant version. If you need more help, call CDC-INFO at 800-232-4636.

КІР

Більш серйозний, ніж звичайна висипка

СИЛА, ЯКА ЗАХИЩАЄ.

КІР МОЖЕ БУТИ 

НЕБЕЗПЕЧНИЙ

Особливо для немовлят 

і малих дітей 

Кір може призвести до...

пневмонії 

(небезпечна легенева 

інфекція)

пошкодження мозку

глухоти

смерті

СИМПТОМИ КОРУ

ІЗ 5 ХВОРИХ НА КІР 

ПРИБЛИЗНО 

1 ЛЮДИНА 

ГОСПІТАЛІЗУЄТЬСЯ.

ПОЧЕРВОНІННЯ 

ОЧЕЙ

КАШЕЛЬ

ВИСИП У ВИГЛЯДІ 

ДРІБНИХ 

ЧЕРВОНИХ ПЛЯМ

(ПОЧИНАЄТЬСЯ НА 

ГОЛОВІ)

НЕЖИТЬ

ДІАРЕЯ

ЗАПАЛЕННЯ ВУХА

КІР Є ДУЖЕ 

ЗАРАЗНИМ

Ось як він поширюється...

КАШЕЛЬ І 

ЧХАННЯ

ЗАТРИМКА МІКРОБІВ 

(МОЖУТЬ ЗАЛИШИТИСЯ 

В КІМНАТІ ПРОТЯГОМ 

ТРИВАЛОГО ЧАСУ ПІСЛЯ 

ТОГО, ЯК ХВОРА 

ЛЮДИНА ЇЇ ОПУСТИТЬ!)

КІР НАВКРУГИ СВІТУ

Кір панує в багатьох частинах 

світу і цей вірус можна будь-коли 

привезти до США.

ЗАХИСТІТЬ СВОЮ ДИТИНУ

Вакцина КПК захищає від кору, паротиту та 

краснухи. Лікарі рекомендують дати вашій дитині 

2 дози щеплення КПК для найкращого захисту.

Вашій дитині треба дати одну дозу щеплення 

в кожному поданому віці...

ДОЗА No1 ДОЗА No2

12–15 місяців 4–6 років

Немовлята віком від 6 до 11 місяців, перед виїздом закордон, 

повинні отримати 1 дозу щеплення КПК.

ІМУНІЗАЦІЯ.

Дізнайтеся більше за посиланням 

www.cdc.gov/vaccines/parents
Caminar todos 

los días me hace 

sentir como antes. 

Bueno, casi.

Sharon, 58 años, Illinois 

Diagnosticada de cáncer a los 37 años

Sharon fumaba. Dejó de hacerlo, pero 

no antes de que le apareciera el cáncer 

de garganta. El tumor le dificultaba la 

respiración y por eso no podía caminar 

mucho. Desde que le extirparon la laringe, 

respira a través del cuello. Sabe que su vida 

nunca volverá a ser como antes. 

Usted puede dejar de fumar.

Para recibir ayuda gratuita, llame al

1-855-DÉJELO-YA.

#CDCConsejos

Solamente impreso
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF COYNE INTERNATIONAL ENTERPRISES CORP. AND
SUBSIDIARIES FOR THE QUARTER ENDED JULY 31,1999 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                                       0001066242
<NAME>            COYNE INTERNATIONAL ENTERPRISES CORP.

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               JUL-31-1999
<CASH>                                         578,375
<SECURITIES>                                         0
<RECEIVABLES>                               15,770,894
<ALLOWANCES>                                         0
<INVENTORY>                                  7,855,898
<CURRENT-ASSETS>                            52,456,956
<PP&E>                                      94,539,580
<DEPRECIATION>                              48,056,304
<TOTAL-ASSETS>                             122,016,835
<CURRENT-LIABILITIES>                       32,059,906
<BONDS>                                     96,736,510
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  4,806,200
<COMMON>                                           769
<OTHER-SE>                                (12,848,793)
<TOTAL-LIABILITY-AND-EQUITY>               122,016,835
<SALES>                                      2,708,631
<TOTAL-REVENUES>                            36,423,371
<CGS>                                        1,791,930
<TOTAL-COSTS>                               34,626,241
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,689,992
<INCOME-PRETAX>                              (892,862)
<INCOME-TAX>                                 (282,000)
<INCOME-CONTINUING>                          (610,862)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (610,862)
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
No. 11-243.

#### Juan J. Salazar, et al., Petitioners v. City of Maywood, California, et al.

565 U.S. 977, 132 S. Ct. 502,

181 L. Ed. 2d 348,

2011 U.S. LEXIS 7878.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 414 Fed. Appx. 73.
[Federal Register Volume 63, Number 142 (Friday, July 24, 1998)]
[Notices]
[Pages 39885-39886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19732]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Land Management
[AZ-020-08-A155; AZA-29932]


Notice of Realty Action Noncompetitive Sale of Public Lands in 
Maricopa County, Arizona

AGENCY: City of Glendale, BLM, Interior.

ACTION: Notice of Realty Action, Noncompetitive Sale.

-----------------------------------------------------------------------

SUMMARY: The following public lands have been found suitable for direct 
sale under Section 203 of the Federal Land Policy and Management Act of 
1976 (90 Stat. 2750; 43 U.S.C. 1713), at not less

[[Page 39886]]

than the estimated fair market value to be established by appraisal. 
The City of Glendale proposes to use the lands for an expansion to the 
already existing landfill operation. The land will not be offered for 
sale for at least 60 days after the date of this notice in the Federal 
Register.

Gila and Salt River Meridian, Arizona

T. 2 N., R. 1 W.,
    Sec. 1, E\1/2\SE\1/4\.

    The area described contains 80 acres in Maricopa County.

    The land described above is hereby segregated from appropriation 
under the public land laws including the mining laws, pending 
disposition of this action or 270 days from the date of publication of 
this notice, whichever occurs first. It has been determined that there 
are no known mineral values, therefore the mineral interests shall be 
determined suitable for sale under Section 209 of the Federal Land 
Policy and Management Act of 1976 (90 Stat. 2727; 43 U.S.C. 1719) and 
may be conveyed simultaneously.
    The conveyance document, when issued, will contain certain 
reservations to the United States and will be subject to any existing 
rights-of-way and any other valid existing rights. Detailed information 
concerning this sale is available for review at the Phoenix Field 
Office, Bureau of Land Management, 2015 West Deer Valley Road, Phoenix, 
Arizona 85027.
    For a period of 45 days from the date of publication of this notice 
in the Federal Register, interested parties may submit comments to the 
Field Office Manager, Phoenix Field Office, at the above address.
    In the absence of timely objections, this proposal shall become the 
final determination of the Department of the Interior.

    Dated: July 14, 1998.
Sandra R. Nelson,
Acting Assistant Field Manager, Support Services.
[FR Doc. 98-19732 Filed 7-23-98; 8:45 am]
BILLING CODE 4310-32-M
I 

116TH CONGRESS 

1ST SESSION H. R. 3050 

To require the Securities and Exchange Commission to carry out a study 

of the 10 per centum threshold limitation applicable to the definition 

of a diversified company under the Investment Company Act of 1940, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 30, 2019 

Mr. STEIL introduced the following bill; which was referred to the Committee 

on Financial Services 

A BILL 

To require the Securities and Exchange Commission to carry 

out a study of the 10 per centum threshold limitation 

applicable to the definition of a diversified company 

under the Investment Company Act of 1940, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Expanding Investment 

5 in Small Businesses Act of 2019’’. 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 3050 IH

1 SEC. 2. SEC STUDY. 

2 (a) IN GENERAL.—The Securities and Exchange 

3 Commission shall carry out a study of the 10 per centum 

4 threshold limitation applicable to the definition of a diver5 sified company under section 5(b)(1) of the Investment 

6 Company Act of 1940 (15 U.S.C. 80a–5(b)(1)) and deter7 mine whether such threshold limits capital formation. 

8 (b) CONSIDERATIONS.—In carrying out the study re9 quired under subsection (a), the Commission shall con10 sider the following: 

11 (1) The size and number of diversified compa12 nies that are currently restricted in their ability to 

13 own more than 10 percent of the voting shares in an 

14 individual company. 

15 (2) If investing preferences of diversified com16 panies have shifted away from companies with small17 er market capitalizations. 

18 (3) The expected increase in the availability of 

19 capital to small and emerging growth companies if 

20 the threshold is increased. 

21 (4) The ability of registered funds to manage li22 quidity risk. 

23 (5) Any other consideration that the Commis24 sion considers necessary and appropriate for the pro25 tection of investors. 


pamtmann on DSKBFK8HB2PROD with BILLS
3 

•HR 3050 IH

1 (c) SOLICITATION OF PUBLIC COMMENTS.—In car2 rying out the study required under subsection (a), the 

3 Commission may solicit public comments. 

4 (d) REPORT.—Not later than the end of the 180-day 

5 period beginning on the date of enactment of this Act, the 

6 Commission shall issue a report to the Congress, and 

7 make such report publicly available on the website of the 

8 Commission, containing— 

9 (1) all findings and determinations made in car10 rying out the study required under subsection (a); 

11 and 

12 (2) any legislative recommendations of the 

13 Commission, including any recommendation to up14 date the 10 per centum threshold. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS